Skip to main content
logo
Zelira Therapeutics Limited (ASX:ZLD)
Australia flag Australia · Delayed Price · Currency is AUD
0.5000
0.00 (0.00%)
Feb 27, 2026, 3:55 PM AEST

Zelira Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
65317951
Market Cap Growth
11.54%64.76%-81.46%84.44%-81.85%-1.91%
Enterprise Value
812518343
Last Close Price
0.500.440.281.510.977.53

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
9067.957979.8033.4656.906.0377.16
PB Ratio
-1.39-1.22-0.760.540.261.35
P/TBV Ratio
---70.092.668.59

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
-18174.2254.6858.871.8864.93

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
-0.50-0.50-1.430.010.010.02
Net Debt / Equity Ratio
-0.50-0.50-1.280.01-0.06-0.12
Net Debt / EBITDA Ratio
-0.51-0.51-0.97-0.040.180.49
Net Debt / FCF Ratio
-0.43-0.43-1.22-0.040.240.51
Asset Turnover
000.010.010.040.02
Inventory Turnover
0.930.930.240.360.67-
Quick Ratio
0.010.010.410.081.854.68
Current Ratio
0.110.110.600.943.125.66
Return on Equity (ROE)
---266.82%-18.60%-33.77%-23.62%
Return on Assets (ROA)
-83.30%-83.30%-18.87%-12.51%-21.42%-15.60%
Return on Capital Employed (ROCE)
100.70%100.70%308.80%-22.40%-36.60%-24.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-60.99%-69.30%-1150.98%-32.53%-128.58%-16.70%
FCF Yield
-82.49%-93.74%-138.13%-42.31%-101.48%-16.84%
Buyback Yield / Dilution
-1.20%-1.20%-12.70%-25.19%-21.25%-36.81%